The DOI matches its Crossref record.
Differential Distribution of 5Ht1D-and 5HT1B-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs
Abstract
Sumatriptan, a 5HT 1B/1D-receptor agonist, is clinically effective as an antimigraine agent. Its therapeutic action may result partly from vasoconstriction of excessively dilated cranial blood vessels (a 5HT 1B-receptor mediated response). The antimigraine activity of sumatriptan may also result from inhibition of the release of vasoactive neuropeptides from trigeminal sensory fibres within the meninges. The identity of the 5HT 1B/1D-receptor subtype mediating this effect is unknown. Using 5HT 1D- and 5HT 1B-receptor-specific antibodies we have demonstrated a differential distribution of these receptor subtypes within the human trigemino-cerebrovascular system. Only 5HT 1B-receptor protein was detected on dural arteries. In contrast, only 5HT 1D-receptor protein was detected on trigeminal sensory neurones including peripheral and central projections to dural blood vessels and to the medulla. Within the medulla 5HT 1D-receptor protein was confined to discrete areas associated with the trigeminal sensory system. These findings have important implications for the design of new antimigraine drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Migraine — Current Understanding and Treatment
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010917 · Cited by 1,918
Triptans in Migraine: A Comparative Review of Pharmacology, Pharmacokinetics and Efficacy
Tfelt-Hansen, P., De Vries, P., & Saxena, P. R. (2000) · Drugs · doi:10.2165/00003495-200060060-00003 · Cited by 529
Silberstein, S. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15440-8 · Cited by 420
Orofacial pain management: current perspectives
Romero-Reyes, M., & Uyanik, J. M. (2014) · Journal of Pain Research · doi:10.2147/jpr.s37593 · Cited by 303
Metadata
- Authors
- Longmore, J., Shaw, D., Smith, D., Hopkins, R., McAlliste, G., Pickard, J., Sirinathsinghji, D., Butler, A., & Hill, R.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 1997-12
- Volume
- 17
- Issue
- 8
- Pages
- 833-842
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2017208290
- Cited by
- 221
- References
- 0
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Distribution of 5Ht1D-and 5HT1B-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs. https://app.cochat.ai/papers/10.1046/j.1468-2982.1997.1708833.x
- The paper
- Longmore, J., Shaw, D., Smith, D., Hopkins, R., McAlliste, G., Pickard, J., Sirinathsinghji, D., Butler, A., & Hill, R. (1997). Differential Distribution of 5Ht1D-and 5HT1B-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs. Cephalalgia. https://doi.org/10.1046/j.1468-2982.1997.1708833.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.